{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:23:27Z","timestamp":1794273807995,"version":"4.9.0"},"reference-count":32,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T00:00:00Z","timestamp":1139270400000},"content-version":"vor","delay-in-days":2808,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Patients with homozygous \u03b2\u2010thalassemia are chronically transfused and, if not assiduously chelated, are at risk for cardiac dysfunction. Available data suggest that even in optimally chelated patients, cardiac pathology is abnormal secondary to iron deposition, fibrosis, hypertrophy, and the structural effects of chronic anemia. Evidence of myopericarditis may also be found. Cardiac performance is usually only subtly affected, primarily with diastolic abnormalities not routinely detected on echocardiograms or nuclear scan. In poorly chelated patients, severe heart failure occurs and is easily predictable but invariably fatal, despite treatment with diuretics, vasodilators, inotropes, and antiarrhythmics. Based on successful prevention of heart failure with ACE inhibitors in other forms of cardiomyopathy, we suggest multicenter trials to explore methods to stabilize cardiac function in patients at risk for iron\u2010induced heart disease. Long\u2010term adverse effects of iron deposition, diastolic dysfunction, and abnormal hormone regulation need to be quantitated in patients reaching their third and fourth decades when the potential for ischemic cardiac disease could compound cardiac dysfunction.<\/jats:p>","DOI":"10.1111\/j.1749-6632.1998.tb10481.x","type":"journal-article","created":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T09:37:23Z","timestamp":1139305043000},"page":"242-250","source":"Crossref","is-referenced-by-count":47,"title":["Diagnosis and Management of Iron\u2010induced Heart Disease in Cooley's Anemia"],"prefix":"10.1111","volume":"850","author":[{"given":"MARIELL","family":"JESSUP","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CATHERINE S.","family":"MANNO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,2,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.30.5.698"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1980.tb33678.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90264-X"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409013310902"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409013310903"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1993.tb04722.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.98.5.1138"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.88.3.1127"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.87.3.748"},{"key":"e_1_2_6_11_2","first-page":"93","article-title":"Left ventricular function in thalassemia major: Protective effect of deferoxamine","volume":"10","author":"Desideri A.","year":"1994","journal-title":"Can. J. Cardiol."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90066-5"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/14.12.719"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(71)90240-3"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.35.4.631"},{"key":"e_1_2_6_16_2","first-page":"66","article-title":"Myocarditis in \u03b2\u2010thalassemia major","volume":"91","author":"Kremastinos D. T.","year":"1995","journal-title":"A cause of heart failure. Circulation"},{"key":"e_1_2_6_17_2","first-page":"288","article-title":"Management of cardiac complications in patients with thalassemia major","volume":"32","author":"Vecchio C.","year":"1995","journal-title":"Sem. Hematol."},{"key":"e_1_2_6_18_2","first-page":"980","article-title":"The left ventricular end\u2010systolic pressure\u2010dimension relation in patients with thalassemia major","volume":"66","author":"Borow K. M.","year":"1982","journal-title":"A new non-invasive method for assessing contractile state. Circulation"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197911223012103"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.64.5.952"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.3.778"},{"key":"e_1_2_6_22_2","first-page":"1061","article-title":"Cardiac transplantation: Recipient selection, donor procurement, and medical follow\u2010up: A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology","volume":"86","author":"O'Connell J. B.","year":"1992","journal-title":"American Heart Association. Circulation"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)90439-2"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.73.5.486"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/10731199409117403"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404213301605"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.482693.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_F.4"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00192352"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1542\/peds.97.3.352","article-title":"The changing profile of homozygous \u03b2\u2010thalassemia: Demography, ethnicity, and age distribution of current North American patients and changes in two decades","volume":"97","author":"Pearson H. A.","year":"1996","journal-title":"Pediatrics"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90991-4"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90252-4"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960X(95)90037-3"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.1998.tb10481.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.1998.tb10481.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:45:15Z","timestamp":1695696315000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.1998.tb10481.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1111\/j.1749-6632.1998.tb10481.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb10481.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}